[5alpha-dihydrotestosterone (DHT)].
Komiya
Akira
A
Department of Urology, Chiba University Hospital.
Suzuki
Hiroyoshi
H
Ichikawa
Tomohiko
T
D013741:3-Oxo-5-alpha-Steroid 4-Dehydrogenase / Q000172:deficiency; D058891:5-alpha Reductase Inhibitors; D015415:Biomarkers / Q000097:blood; D003940:Diagnostic Techniques, Endocrine; D013196:Dihydrotestosterone / Q000097:blood* / Q000378:metabolism; D004791:Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D005260:Female; D005262:Feminization / Q000175:diagnosis / Q000209:etiology; D018120:Finasteride / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007527:Isoenzymes; D008297:Male; D011470:Prostatic Hyperplasia / Q000175:diagnosis / Q000188:drug therapy; D011863:Radioimmunoassay / Q000379:methods; D011944:Receptors, Androgen / Q000378:metabolism
D058891:5-alpha Reductase Inhibitors; D015415:Biomarkers; D004791:Enzyme Inhibitors; D007527:Isoenzymes; D011944:Receptors, Androgen; D013196:Dihydrotestosterone; D018120:Finasteride; D013741:3-Oxo-5-alpha-Steroid 4-Dehydrogenase